A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Aging science has recently drawn much attention, and discussions on the possibility of anti-aging medicine have multiplied. One potential target for the development of anti-aging drugs is the SIR2 (silent information regulator 2) family of NAD-dependent deacetylases/ADP-ribosyltransferases, called “sirtuins.” Sirtuins regulate many fundamental biological processes in response to a variety of environmental and nutritional stimuli. In mammals, the mammalian SIR2 ortholog SIRT1 has been most studied, and small molecule SIRT1 activators (STACs), including a plant-derived polyphenolic compound resveratrol, have been developed. On the other hand, sirtuin activity is regulated by NAD biosynthetic pathways, and nicotinamide phosphoribosyltransferase (NAMPT) plays a critical role in the regulation of mammalian sirtuin activity. Recent studies have provided a proof of concept for the idea that nicotinamide mononucleotide (NMN), the NAMPT reaction product, can be used a nutriceutical to activate SIRT1 activity. Based on these recent findings, the possibility of sirtuin-targeted nutriceutical development will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Sir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126
Self-citationMechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration
Lin, S.-J., Kaeberlein, M., Andalis, A. A., Sturtz, L. A., Defossez, P.-A., Culotta, V. C., Fink, G. R., & Guarente, L. (2002) · Nature · doi:10.1038/nature00829 · Cited by 1,057
Research works printed but not linked: 51
- Stagnitti MN. Trends in statins utilization and expenditures for the U.S. Civilian noninstitutionalized population, 2000 and 2005. In: Quality AfHRa (Ed.), 2008.
- Blagosklonny, 2007, An anti-aging drug today: from senescence-promoting genes to anti-aging pill, Drug Discov Today, 12, 218, 10.1016/j.drudis.2007.01.004 · DOI
- Wick, 2002, ‘Anti-aging’ medicine: does it exist? A critical discussion of ‘anti-aging health products’, Exp Gerontol, 37, 1137, 10.1016/S0531-5565(02)00081-5 · DOI
- Ho, 2009, Anti-aging herbal medicine-how and why can they be used in aging-associated neurodegenerative diseases?, Ageing Res Rev
- Imai, 2000, Transcriptional silencing and longevity protein SIR2 is an nad-dependent histone deacetylase, Nature, 403, 795, 10.1038/35001622 · DOI · Paper page
- Blander, 2004, The Sir2 family of protein deacetylases, Annu Rev Biochem, 73, 417, 10.1146/annurev.biochem.73.011303.073651 · DOI · Paper page
- Astrom, 2003, The drosophila melanogaster sir2+ gene is nonessential and has only minor effects on position-effect variegation, Genetics, 163, 931, 10.1093/genetics/163.3.931 · DOI · Paper page
- Howitz, 2003, Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 · DOI · Paper page
- Tissenbaum, 2001, Increased dosage of a sir-2 gene extends lifespan in caenorhabditis elegans, Nature, 410, 227, 10.1038/35065638 · DOI · Paper page
- Wang, 2006, Overlapping and distinct functions for a caenorhabditis elegans sir2 and daf-16/foxo, Mech Ageing Dev, 127, 48, 10.1016/j.mad.2005.09.005 · DOI · Paper page
- Imai, 2009, The NAD World: a new systemic regulatory network for metabolism and aging - Sirt1, systemic NAD biosynthesis, and their importance, Cell Biochem Biophys, 53, 65, 10.1007/s12013-008-9041-4 · DOI · Paper page
- Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem J, 404, 1, 10.1042/BJ20070140 · DOI · Paper page
- Schwer, 2008, Conserved metabolic regulatory functions of sirtuins, Cell Metab, 7, 104, 10.1016/j.cmet.2007.11.006 · DOI · Paper page
- Imai, 2009, Therapeutic potential of sirt1 and nampt-mediated nad biosynthesis in type 2 diabetes, Front Biosci, 14, 2983, 10.2741/3428 · DOI · Paper page
- Milne, 2008, The sirtuin family: therapeutic targets to treat diseases of aging, Curr Opin Chem Biol, 12, 11, 10.1016/j.cbpa.2008.01.019 · DOI · Paper page
- Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354 · DOI · Paper page
- Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating Sirt1 and Pgc-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013 · DOI · Paper page
- Pearson, 2008, Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span, Cell Metab, 8, 157, 10.1016/j.cmet.2008.06.011 · DOI · Paper page
- Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060 · DOI · Paper page
- Smith, 2009, Small molecule activators of sirt1 replicate signaling pathways triggered by calorie restriction in vivo, BMC Syst Biol, 3, 31, 10.1186/1752-0509-3-31 · DOI · Paper page
- Yamazaki, 2009, Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in msg mice, Am J Physiol Endocrinol Metab, 10.1152/ajpendo.90997.2008 · DOI · Paper page
- Westphal, 2007, A therapeutic role for sirtuins in diseases of aging?, Trends Biochem Sci, 32, 555, 10.1016/j.tibs.2007.09.008 · DOI · Paper page
- Holub, 2004, Omega-3 fatty acids from fish oils and cardiovascular disease, Mol Cell Biochem, 263, 217, 10.1023/B:MCBI.0000041863.11248.8d · DOI · Paper page
- Martin, 2008, Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development, Cardiovasc Hematol Disord Drug Targets, 8, 297, 10.2174/187152908786786214 · doi:10.2174/187152908786786214
- Denu, 2003, Linking chromatin function with metabolic networks: Sir2 family of nad(+)-dependent deacetylases, Trends Biochem Sci, 28, 41, 10.1016/S0968-0004(02)00005-1 · DOI · Paper page
- Lin, 2003, Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease, Curr Opin Cell Biol, 15, 241, 10.1016/S0955-0674(03)00006-1 · DOI · Paper page
- Anderson, 2002, Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state nad+ levels, J Biol Chem, 277, 18881, 10.1074/jbc.M111773200 · DOI · Paper page
- Sandmeier, 2002, Telomeric and rdna silencing in saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway, Genetics, 160, 877, 10.1093/genetics/160.3.877 · DOI · Paper page
- Yang, 2006, Nampt/pbef/visfatin: a regulator of mammalian health and longevity?, Exp Gerontol, 41, 718, 10.1016/j.exger.2006.06.003 · DOI
- Magni, 1999, Enzymology of NAD+ synthesis, Adv Enzymol Relat Areas Mol Biol, 73, 135
- Rongvaux, 2003, Reconstructing eukaryotic nad metabolism, Bioessays, 25, 683, 10.1002/bies.10297 · DOI · Paper page
- Garten, 2009, Nampt: linking nad biology, metabolism and cancer, Trends Endocrinol Metab, 20, 130, 10.1016/j.tem.2008.10.004 · DOI · Paper page
- Imai, 2009, Nicotinamide phosphoribosyltransferase (Nampt): a link between nad biology, metabolism, and diseases, Curr Pharm Des, 15, 20, 10.2174/138161209787185814 · DOI · Paper page
- Lau, 2009, The NMN/NaMN adenylyltransferase (nmnat) protein family, Front Biosci, 14, 410, 10.2741/3252 · DOI · Paper page
- Preiss, 1957, Enzymatic synthesis of nicotinamide mononucleotide, J Biol Chem, 225, 759, 10.1016/S0021-9258(18)64875-6 · DOI · Paper page
- Martin, 2001, Identification of a plasmid-encoded gene from haemophilus ducreyi which confers nad independence, J Bacteriol, 183, 1168, 10.1128/JB.183.4.1168-1174.2001 · DOI · Paper page
- Miller, 2003, Complete genome sequence of the broad-host-range vibriophage kvp40: comparative genomics of a t4-related bacteriophage, J Bacteriol, 185, 5220, 10.1128/JB.185.17.5220-5233.2003 · DOI · Paper page
- Garten, 2009, Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes, Biochem Biophys Res Commun
- Zhang, 2009, Enzymes in the NAD+ salvage pathway regulate sirt1 activity at target gene promoters, J Biol Chem, 284, 20408, 10.1074/jbc.M109.016469 · DOI · Paper page
- van der Veer, 2005, Pre-b-cell colony-enhancing factor regulates nad+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation, Circ Res, 97, 25, 10.1161/01.RES.0000173298.38808.27 · DOI · Paper page
- van der Veer, 2007, Extension of human cell lifespan by nicotinamide phosphoribosyltransferase, J Biol Chem, 282, 10841, 10.1074/jbc.C700018200 · DOI · Paper page
- Ho, 2009, Sirt1 markedly extends replicative lifespan if nad(+) salvage is enhanced, FEBS Lett, 10.1016/j.febslet.2009.08.031 · DOI · Paper page
- Fulco, 2008, Glucose restriction inhibits skeletal myoblast differentiation by activating Sirt1 through ampk-mediated regulation of nampt, Dev Cell, 14, 661, 10.1016/j.devcel.2008.02.004 · DOI · Paper page
- Skokowa, 2009, Nampt is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway, Nat Med, 15, 151, 10.1038/nm.1913 · DOI · Paper page
- Pillai, 2005, Poly(adp-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity, J Biol Chem, 280, 43121, 10.1074/jbc.M506162200 · DOI · Paper page
- Hsu, 2009, Nicotinamide phosphoribosyltransferase regulates cell survival through nad+ synthesis in cardiac myocytes, Circ Res, 105, 481, 10.1161/CIRCRESAHA.109.203703 · DOI · Paper page
- Moynihan, 2005, Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice, Cell Metab, 2, 105, 10.1016/j.cmet.2005.07.001 · DOI · Paper page
- Broetto-Biazon, 2004, The action of extracellular nad+ on ca2+ efflux, hemodynamics and some metabolic parameters in the isolated perfused rat liver, Eur J Pharmacol, 484, 291, 10.1016/j.ejphar.2003.11.024 · doi:10.1016/j.ejphar.2003.11.024
- Iozzo, 1999, Independent influence of age on basal insulin secretion in nondiabetic humans: European group for the study of insulin resistance, J Clin Endocrinol Metab, 84, 863, 10.1210/jcem.84.3.5542 · doi:10.1210/jcem.84.3.5542 · Paper page
- Muzumdar, 2004, Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action, Diabetes, 53, 441, 10.2337/diabetes.53.2.441 · DOI · Paper page
- Williams, 2007, Pellagra: a clue as to why energy failure causes diseases?, Med Hypotheses, 69, 618, 10.1016/j.mehy.2007.01.029 · DOI
Cited by
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
“Whereas these compounds were originally developed as pharmaceutical drugs, some endogenous compounds might also have the potential to achieve healthy and productive lives even at a very old age (Imai, 2010; Imai and Guarente, 2014).”
Self-citationCircadian Clock NAD + Cycle Drives Mitochondrial Oxidative Metabolism in Mice
Peek, C. B., Affinati, A. H., Ramsey, K. M., Kuo, H.-Y., Yu, W., Sena, L. A., Ilkayeva, O., Marcheva, B., Kobayashi, Y., Omura, C., et al. (2013) · Science · doi:10.1126/science.1243417 · Cited by 652
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588
Picciotto, N. E., Gano, L. B., Johnson, L. C., Martens, C. R., Sindler, A. L., Mills, K. F., Imai, S., & Seals, D. R. (2016) · Aging Cell · doi:10.1111/acel.12461 · Cited by 396
Self-citationTen years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases
Imai, S.-I., & Guarente, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.003 · Cited by 390
Self-citation
Metadata
- Authors
- Imai, S.-I.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 62
- Issue
- 1
- Pages
- 42-47
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2013162028
- Cited by
- 89
- References
- 27
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. https://app.cochat.ai/papers/10.1016/j.phrs.2010.01.006
- The paper
- Imai, S.-I. (2010). A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacological Research. https://doi.org/10.1016/j.phrs.2010.01.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.